awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q44286888-6F7E5F0C-B5D3-4D53-A7F9-7652BF207FCD
Q44286888-6F7E5F0C-B5D3-4D53-A7F9-7652BF207FCD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44286888-6F7E5F0C-B5D3-4D53-A7F9-7652BF207FCD
Drugs for improving esophageal mucosa defense: where are we now and where are we going?
P2860
Q44286888-6F7E5F0C-B5D3-4D53-A7F9-7652BF207FCD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44286888-6F7E5F0C-B5D3-4D53-A7F9-7652BF207FCD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
55423ed401f21e70ddb447936c90b421281dcf5f
P2860
Randomised clinical trial: addition of alginate-antacid (Gaviscon Double Action) to proton pump inhibitor therapy in patients with breakthrough symptoms.